Medtronic sent a warning letter to doctors alerting them to proceed with caution when using the minimally invasive EnVeo R delivery system, the Star Tribune reports. The newspaper noted that Medtronic voluntarily updated instructions for using the system after reports emerged of 19 patients dying from severe blood vessel trauma.
The EnVeo R delivery system is used to implant the Evolut R transcatheter aortic valve replacement system in the heart of patients with severe aortic stenosis.
Read the full article below:
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.